HR
AZN icon

Howe & Rusling’s AstraZeneca AZN Stock Holding History

Howe & Rusling’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.5M Buy
+53,182
New +$10.3M 0.68% 44
2025
Q4 		– Sell
-58,797
Closed -$9.02M – 480
2025
Q3 		$9.02M Buy
58,797
+204
+0.3% +$30.9K 0.62% 51
2025
Q2 		$8.19M Sell
58,593
-1,963
-3% -$275K 0.6% 49
2025
Q1 		$8.9M Sell
60,556
-17,677
-23% -$2.56M 0.75% 41
2024
Q4 		$10.3M Buy
78,233
+18,327
+31% +$2.57M 0.88% 31
2024
Q3 		$9.33M Sell
59,906
-14,892
-20% -$2.4M 0.8% 36
2024
Q2 		$11.7M Sell
74,798
-5,931
-7% -$892K 1.06% 28
2024
Q1 		$10.9M Buy
80,729
+2,481
+3% +$329K 1.05% 30
2023
Q4 		$10.5M Buy
78,248
+14,141
+22% +$1.84M 1.12% 30
2023
Q3 		$8.68M Sell
64,107
-267
-0.4% -$36.5K 1.02% 35
2023
Q2 		$9.21M Sell
64,374
-10,428
-14% -$1.53M 1.03% 32
2023
Q1 		$10.4M Buy
74,802
+1,261
+2% +$170K 1.24% 28
2022
Q4 		$9.97M Buy
73,541
+2,415
+3% +$303K 1.25% 27
2022
Q3 		$7.8M Buy
71,126
+35,929
+102% +$4.56M 1.04% 33
2022
Q2 		$4.65M Buy
+35,197
New +$4.62M 0.59% 58
2020
Q4 		– Sell
-55
Closed -$6K – 933
2020
Q3 		$6K Buy
+55
New +$6.12K ﹤0.01% 511
2019
Q2 		– Sell
-142
Closed -$11K – 811
2019
Q1 		$11K Buy
+142
New +$11.2K ﹤0.01% 432
2017
Q4 		– Sell
-859
Closed -$58K – 840
2017
Q3 		$58K Buy
859
+523
+156% +$33K 0.01% 288
2017
Q2 		$23K Buy
336
+275
+451% +$18K ﹤0.01% 357
2017
Q1 		$4K Hold
61
– – ﹤0.01% 694
2016
Q4 		$3K Sell
61
-179
-75% -$10.2K ﹤0.01% 765
2016
Q3 		$16K Sell
240
-58
-19% -$3.79K ﹤0.01% 410
2016
Q2 		$18K Hold
298
– – ﹤0.01% 367
2016
Q1 		$17K Hold
298
– – ﹤0.01% 426
2015
Q4 		$20K Buy
+298
New +$19.5K ﹤0.01% 382
2013
Q3 		– Sell
-47
Closed -$2K – 877
2013
Q2 		$2K Buy
+47
New +$2.39K ﹤0.01% 799

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Howe & Rusling's AZN Position: Q1 2026 in Review

Howe & Rusling opened a new position in AstraZeneca (AZN) in Q1 2026: 53,182 shares worth $10.5M. The stake represents 0.68% of the portfolio and ranks #44 among its holdings. This is a return to the name: Howe & Rusling previously reported a position in AZN as recently as Q3 2025.

Howe & Rusling first reported a position in AZN in Q2 2013 and has held it in 26 quarters since. The position peaked at $11.7M in Q2 2024. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Howe & Rusling held 53,182 shares of AstraZeneca worth $10.5M as of Q1 2026.
  • AstraZeneca was a new Howe & Rusling position in Q1 2026.
  • AstraZeneca made up 0.68% of Howe & Rusling's portfolio in Q1 2026, its #44 holding.
  • Howe & Rusling first reported a position in AstraZeneca in Q2 2013 and has held it in 26 quarters since.
  • Howe & Rusling's AstraZeneca position peaked at $11.7M in Q2 2024.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Howe & Rusling's 13F filing for Q1 2026, filed 28 Apr 2026.